1. | jjhale69 | |
2. | greatLegends45 | |
3. | evanrude6233 | |
4. | ezekielprincetyr | |
5. | poeticrayjohn |
1. | jjhale69 | |
2. | greatLegends45 | |
3. | evanrude6233 | |
4. | ezekielprincetyr | |
5. | poeticrayjohn |
1. | evanrude6233 01/22/2018 Athenex Announces Encouraging Early Clinical Efficacy and Safety Data of Oraxol in Clinical Trial for the Treatment of Breast Cancer |
2. | ezekielprincetyr 10/23/2018 ESMO 2018: Athenex Presented Encouraging Clinical Trial Efficacy and Safety Results of Oraxol in the Treatment of Metastatic Breast Cancer |
3. | evanrude6233 09/06/2018 Announces positive recommendation by DSMB |
4. | greatLegends45 12/28/2017 Athenex Receives Promising Innovative Medicine Designation from the United Kingdom MHRA for Oraxol, An Innovative Oral Form of Paclitaxel |
5. | jjhale69 02/15/2018 You better bought on last weeks dip!!! |
6. | jjhale69 03/26/2018 Athenex, Inc. Announces Fourth Quarter and Full-Year 2017 Results |
7. | ezekielprincetyr 04/19/2018 Receives Orphan Drug Designation from the FDA for Oraxol |
8. | greatLegends45 02/15/2018 CHANGE: 1.12 (7.2%) |
9. | greatLegends45 01/22/2018 Stock Offering News |